Selahattin Tunc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Selahattin Tunc has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Azibe Yildiz
Department of Histology and Embryology, Faculty of Medicine, Inonu University, Malatya, Turkey
3 shared publications - Yilmaz Cigremis
Inonu University
3 shared publications - Hakan Parlakpinar
Department of Pharmacology, Faculty of Medicine, Inonu University, Malatya, Turkey
2 shared publications - Nigar Vardi
Department of Histology and Embryology, Faculty of Medicine, Inonu University, Malatya, Turkey
2 shared publications - Onural Ozhan
Department of Pharmacology, Faculty of Medicine, Inonu University, Malatya, Turkey
2 shared publications - Ahmet Sefa Duman
Department of Ophthalmology, Yozgat City Hospital, Merkez, Yozgat, Turkey
1 shared publication
Latest Publications
- Open Access
- 18 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Resveratrol exerts neuroprotective properties by modulating brain SIRT1 gene expression in lipopolysaccharide-induced neuroinflammation in rats
- 18 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessResveratrol exerts neuroprotective properties by modulating brain SIRT1 gene expression in lipopolysaccharide-induced neuroinflammation in rats
- Open Access
- 5 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Electrophysiological, biochemical, and histopathological evidence of thymoquinone-mediated protection in cisplatin-induced cardiotoxicity
- 5 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessElectrophysiological, biochemical, and histopathological evidence of thymoquinone-mediated protection in cisplatin-induced cardiotoxicity
- 29 August 2024
- Published by Ataturk Universitesi in Recent Trends in Pharmacology
- Vol. 2 (2) , 48-57
Carvacrol attenuates amikacin-induced nephrotoxicity in the rats
Objective: Amikacin (AK) is a wide-spectrum antibiotic routinely used to treat gram-negative and some gram-positive bacterial infections. However, its use is limited due to its potential to cause nephrotoxicity due to an increase in reactive oxygen radicals. The main goal of this study was to investigate the effect of carvacrol (CAR) on AK-induced nephrotoxicity in rats. Methods: Thirty-two Sprague Dawley rats were randomly separated into four groups: the control (0.9% NaCl solution and sunflower oil), AK (400 mg/kg), CAR+AK (80 mg/kg CAR+400 mg/kg AK), and AK+CAR (400 mg/kg AK+80 mg/kg CAR) groups. AK and CAR were administered intramuscularly and orally, respectively for 7 days. Blood and kidney tissue samples were collected at the end of the experiment. The level of catalase, superoxide dismutase, malondialdehyde, and reduced glutathione, which are parameters of oxidative stress, were detected while comparing renal function and histopathological changes. Results: Histopathological findings (necrotic changes, dilatation and inflammatory cell infiltration) were significantly greater in the AK group than in the control group. Additionally, significant weight loss was detected in the rats in the AK group. CAR treatment, both before and after AK administration, significantly improved nephrotoxicity histopathologically (p<.05). However, the same improvement was not identified biochemically. Conclusion: CAR treatment significantly improved nephrotoxicity both before and after AK administration, suggesting that carvacrol has a protective effect against AK-induced kidney damage at the histopathological level. Keywords: Antioxidant, amikacin, carvacrol, nephrotoxicity, oxidative stress, rat
- 29 August 2024
- Published by Ataturk Universitesi in Recent Trends in Pharmacology
- Vol. 2 (2) , 48-57
Carvacrol attenuates amikacin-induced nephrotoxicity in the rats
Objective: Amikacin (AK) is a wide-spectrum antibiotic routinely used to treat gram-negative and some gram-positive bacterial infections. However, its use is limited due to its potential to cause nephrotoxicity due to an increase in reactive oxygen radicals. The main goal of this study was to investigate the effect of carvacrol (CAR) on AK-induced nephrotoxicity in rats. Methods: Thirty-two Sprague Dawley rats were randomly separated into four groups: the control (0.9% NaCl solution and sunflower oil), AK (400 mg/kg), CAR+AK (80 mg/kg CAR+400 mg/kg AK), and AK+CAR (400 mg/kg AK+80 mg/kg CAR) groups. AK and CAR were administered intramuscularly and orally, respectively for 7 days. Blood and kidney tissue samples were collected at the end of the experiment. The level of catalase, superoxide dismutase, malondialdehyde, and reduced glutathione, which are parameters of oxidative stress, were detected while comparing renal function and histopathological changes. Results: Histopathological findings (necrotic changes, dilatation and inflammatory cell infiltration) were significantly greater in the AK group than in the control group. Additionally, significant weight loss was detected in the rats in the AK group. CAR treatment, both before and after AK administration, significantly improved nephrotoxicity histopathologically (p<.05). However, the same improvement was not identified biochemically. Conclusion: CAR treatment significantly improved nephrotoxicity both before and after AK administration, suggesting that carvacrol has a protective effect against AK-induced kidney damage at the histopathological level. Keywords: Antioxidant, amikacin, carvacrol, nephrotoxicity, oxidative stress, rat